We will encourage the development of better and cheaper drugs and medical devices for patients

2022-04-26 0 By

Beijing, February 12 (reporter Fu Zhenqiang) On February 12, by the PEOPLE’s Political Consultative Conference · CPPCC Network sponsored by the “improve the pharmaceutical innovation ecology to promote the healthy development of the industry” symposium held in Beijing.Members of the CPPCC National Committee and experts and scholars in the medical field held in-depth discussions on hot topics of innovation and ecological development of China’s pharmaceutical industry, offering suggestions and gathering consensus for the construction of China’s innovative pharmaceutical ecosystem.On February 12, a symposium on “Improving the Pharmaceutical Innovation Ecology and promoting the Healthy Development of the Industry” was held in Beijing, sponsored by the People’s Political Consultative Conference (CPPCC).”We should research and develop more affordable medical devices that can benefit more people, whether they are introduced, digested and absorbed, or copied and improved.At the same time, the development of better and cheaper medicines for patients should also be encouraged.”On the forum, Ge Junbo, a member of the National Committee of the Chinese People’s Political Consultative Conference, academician of the Chinese Academy of Sciences and director of cardiology department of Zhongshan Hospital affiliated to Fudan University, said.Ge Junbo, member of the National Committee of the Chinese People’s Political Consultative Conference, academician of the Chinese Academy of Sciences, and director of the department of cardiology of Zhongshan Hospital affiliated to Fudan University, spoke online.In Ge Junbo’s opinion, pharmaceutical innovation should have a complete innovation chain.So, how should each department in the innovation chain exert its power?”The state does not advocate innovation by encouraging simple copying, otherwise there would be no blood of innovation.It usually takes 15 years or more from research and development, patent filing, animal testing, clinical trials, review and approval, and marketing.”Ge called on relevant departments to keep abreast of innovation trends in the pharmaceutical industry, so that government policymakers can have an in-depth understanding of the development of the industry, while also doing their best to save medical costs for patients and the country.